Home
Research
People
Publications
Directions
Positions Available
Home


 

Hirotaka Watanabe, Ph.D.
hwatanabe1@partners.org
(617)525-4250

BIOGRAPHICAL SKETCH

POSITION TITLE: Research Fellow

EDUCATION:

1994 B.Sc. in Biology - Tohoku University
1996 M.S in Biochemistry - University of Tokyo
2006 Ph.D. in Medical Science, University of Tokyo
   

PROFESSIONAL EXPERIENCE:

1996–2002 Researcher at JAPAN TOBACCO Inc.
2002–2006 Research assistant at University of Tokyo
2006-present Postdoctoral fellow, Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital

PUBLICATIONS:

1. Watanabe H, Saitoh K, Kameda T, Murakami M, Niikura Y, Okazaki S, Morishita Y, Mori S, Yokouchi Y, Kuroiwa A, and Iba H. Chondrocytes as a specific target of ectopic Fos expression in early development. Proc Natl Acad Sci U S A. 94: 3994-3999. 1997.

2. Kameda T, Watanabe H, and Iba H. C-Jun and JunD suppress maturation of chondrocytes. Cell Growth Differ. 8: 495-503. 1997.

3. Murakami M, Sonobe MH, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H, and Iba H. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Oncogene. 14: 2435-2444. 1997.

4. Murakami M, Watanabe H, Niikura Y, Kameda T, Saitoh K, Yamamoto M, Yokouchi Y, Kuroiwa A, Mizumoto K, and Iba H. High-level expression of exogenous genes by replication-competent retrovirus vectors with an internal ribosomal entry site. Gene. 202: 23-29. 1997.

5. Nakamura M, Yokoyama M, Watanabe H, and Matsumoto T. Molecular cloning, organization and localization of the gene for the mouse neuropeptide Y-Y5 receptor. Biochim Biophys Acta. 1328: 83-89. 1997.

6. Nakamura M, Watanabe H, Kubo Y, Yokoyama M, Matsumoto T, Sasai H, and Nishi Y. KQT2, a new putative potassium channel family produced by alternative splicing. Isolation, genomic structure, and alternative splicing of the putative potassium channels. Receptors Channels. 5: 255-271. 1998.

7. Yokoyama M*, Watanabe H*, and Nakamura M. Genomic structure and functional characterization of NBPhox (PMX2B), a homeodomain protein specific to catecholaminergic cells that is involved in second messenger-mediated transcriptional activation. Genomics. 59: 40-50. 1999. (*equally contributed)

8. Watanabe H, Nagata E, Kosakai A, Nakamura M, Yokoyama M, Tanaka K, and Sasai H. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem. 75: 28-33. 2000.

9. Akiyama K, Watanabe H, Tsukada S, and Sasai H. A novel method for constructing gene-targeting vectors. Nucleic Acids Res. 28: E77. 2000.

10. Yamamichi-Nishina M, Ito T, Mizutani T, Yamamichi N, Watanabe H, and Iba H. SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level. J Biol Chem. 278: 7422-7430. 2003.

11. Higuchi T, Orita T, Nakanishi S, Katsuya K, Watanabe H, Yamasaki Y, Waga I, Nanayama T, Yamamoto Y, Munger W, Sun HW, Falk RJ, Jennette JC, Alcorta DA, Li H, Yamamoto T, Saito Y, and Nakamura M. Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem. 279: 1968-1979. 2004.

12. Yamamichi N, Yamamichi-Nishina M, Mizutani T, Watanabe H, Minoguchi S, Kobayashi N, Kimura S, Ito T, Yahagi N, Ichinose M, Omata M, and Iba H. (2005) The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Oncogene. 24: 5471-5481. 2005.

13. Watanabe H, Mizutani T, Haraguchi T, Yamamichi N, Minoguchi S, Yamamichi-Nishina M, Mori N, Kameda T, Sugiyama T, and Iba H. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human non-small cell lung carcinoma cell lines. Oncogene. 25: 470-479. 2006.

14. Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, Watanabe H, Shiogama K, Fujishiro M, Okazaki T, Yahagi N, Haraguchi T, Fujita S, Tsutsumi Y, Omata M, Iba H. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res. 67: 10727-35. 2007

15. Ito T, Watanabe H, Yamamichi N, Kondo S, Tando T, Haraguchi T, Mizutani T, Sakurai K, Fujita S, Izumi T, Isobe T, Iba H. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54 nrb. Biochem J. in press.

 

[send feedback to Galina Slezinger]